Your browser doesn't support javascript.
loading
Minimum important difference of the EQ-5D-5L and EQ-VAS in fibrotic interstitial lung disease.
Tsai, Amy Po Yu; Hur, Seo Am; Wong, Alyson; Safavi, Mohsen; Assayag, Deborah; Johannson, Kerri A; Morisset, Julie; Fell, Charlene; Fisher, Jolene H; Manganas, Hélène; Shapera, Shane; Cox, Gerard; Gershon, Andrea S; Hambly, Nathan; Khalil, Nasreen; To, Teresa; Wilcox, Pearce George; Halayko, Andrew; Kolb, Martin Rj; Ryerson, Christopher J.
Affiliation
  • Tsai APY; The University of British Columbia Department of Medicine, Vancouver, British Columbia, Canada.
  • Hur SA; The University of British Columbia Department of Medicine, Vancouver, British Columbia, Canada.
  • Wong A; The University of British Columbia Department of Medicine, Vancouver, British Columbia, Canada.
  • Safavi M; Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, British Columbia, Canada.
  • Assayag D; Respiratory Evaluation Sciences Program, Collaboration for Outcomes Research and Evaluation, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia, Canada.
  • Johannson KA; McGill University Department of Medicine, Montreal, Quebec, Canada.
  • Morisset J; Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Fell C; Département de Médecine, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
  • Fisher JH; Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Manganas H; University of Toronto Faculty of Medicine, Toronto, Ontario, Canada.
  • Shapera S; Département de Médecine, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
  • Cox G; University of Toronto Faculty of Medicine, Toronto, Ontario, Canada.
  • Gershon AS; Firestone Institute for Respiratory Health, McMaster University Department of Medicine, Hamilton, Ontario, Canada.
  • Hambly N; University of Toronto Faculty of Medicine, Toronto, Ontario, Canada.
  • Khalil N; Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • To T; Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Wilcox PG; Firestone Institute for Respiratory Health, McMaster University Department of Medicine, Hamilton, Ontario, Canada.
  • Halayko A; The University of British Columbia Department of Medicine, Vancouver, British Columbia, Canada.
  • Kolb MR; Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Ryerson CJ; University of Toronto Dalla Lana School of Public Health, Toronto, Ontario, Canada.
Thorax ; 76(1): 37-43, 2021 01.
Article in En | MEDLINE | ID: mdl-33023996
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psychometrics / Pulmonary Fibrosis / Quality of Life Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Thorax Year: 2021 Type: Article Affiliation country: Canada
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psychometrics / Pulmonary Fibrosis / Quality of Life Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Thorax Year: 2021 Type: Article Affiliation country: Canada